Clinical Trial Detail

NCT ID NCT02749708
Title Study of IRX5183 in Relapsed and Refractory Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Indications

acute myeloid leukemia

myelodysplastic/myeloproliferative neoplasm

myelodysplastic syndrome

chronic myelomonocytic leukemia

Therapies

IRX5183

Age Groups: senior adult

No variant requirements are available.